Features of symptoms, diagnosis and treatment of inflammatory bowel diseases in elderly patients

Currently, there has been an increase in cases of inflammatory bowel disease with a late onset in elderly patients, which makes it urgent to study the pathogenesis, clinical features, diagnosis and treatment of inflammatory bowel disease in this age group. Up to 35% of inflammatory bowel disease cas...

Full description

Saved in:
Bibliographic Details
Main Authors: L. V. Tarasova, N. Y. Kucherova, T. E. Stepashina
Format: Article
Language:Russian
Published: Open Systems Publication 2023-04-01
Series:Лечащий Врач
Subjects:
Online Access:https://journal.lvrach.ru/jour/article/view/1044
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849693087214862336
author L. V. Tarasova
N. Y. Kucherova
T. E. Stepashina
author_facet L. V. Tarasova
N. Y. Kucherova
T. E. Stepashina
author_sort L. V. Tarasova
collection DOAJ
description Currently, there has been an increase in cases of inflammatory bowel disease with a late onset in elderly patients, which makes it urgent to study the pathogenesis, clinical features, diagnosis and treatment of inflammatory bowel disease in this age group. Up to 35% of inflammatory bowel disease cases are first diagnosed in patients over 60 years of age. In this category of patients low-manifest forms of inflammatory bowel disease are observed more often than others with a more frequent occurrence of extraintestinal manifestations. Genetics contribute less to the pathogenesis of inflammatory bowel disease and age-related changes (dysbacteriosis, impaired intestinal barrier function, dysregulation of the immune system and regeneration mechanisms) play a more significant role. Ulcerative colitis is more common in older adults. Asymptomatic forms prevail with a relatively stable course. When treating elderly patients the development of geriatric syndromes, multimorbidity, polypharmacy should be taken into account. Particular attention should be paid to the safety of therapy, while maintaining maximum adherence to treatment. Careless prescribing of glucocorticosteroids should be avoided, and if indicated, more often resort to steroid-sparing regimens, especially with the use of 5-aminosalicylic acid preparations, should be used. A prolonged form of mesalazine in the form of microgranules with a semipermeable membrane of ethyl cellulose has a pronounced clinical advantage with a minimal frequency of side effects among this group. When inducing remission in elderly patients with mild to moderate active ulcerative colitis topical glucocorticosteroids may be considered. The advantages of continuing therapy with 5-aminosalicylic acid preparations against the background of the use of genetically engineered biological preparations, thiopurines require further reflection. The risk of surgery in older patients with inflammatory bowel disease is comparable to that of inflammatory bowel disease onset at a young age and does not result in increased surgical morbidity or mortality compared with a younger cohort in the delayed postoperative period.
format Article
id doaj-art-12d641a8b69d4473a55dcad131bd8b6f
institution DOAJ
issn 1560-5175
2687-1181
language Russian
publishDate 2023-04-01
publisher Open Systems Publication
record_format Article
series Лечащий Врач
spelling doaj-art-12d641a8b69d4473a55dcad131bd8b6f2025-08-20T03:20:31ZrusOpen Systems PublicationЛечащий Врач1560-51752687-11812023-04-0102323810.51793/OS.2023.26.2.0051039Features of symptoms, diagnosis and treatment of inflammatory bowel diseases in elderly patientsL. V. Tarasova0N. Y. Kucherova1T. E. Stepashina2Federal State Budgetary Educational Institution of Higher Education I. N. Ulyanov Chuvash State UniversityFederal State Budgetary Educational Institution of Higher Education I. N. Ulyanov Chuvash State UniversityFederal State Budgetary Educational Institution of Higher Education I. N. Ulyanov Chuvash State UniversityCurrently, there has been an increase in cases of inflammatory bowel disease with a late onset in elderly patients, which makes it urgent to study the pathogenesis, clinical features, diagnosis and treatment of inflammatory bowel disease in this age group. Up to 35% of inflammatory bowel disease cases are first diagnosed in patients over 60 years of age. In this category of patients low-manifest forms of inflammatory bowel disease are observed more often than others with a more frequent occurrence of extraintestinal manifestations. Genetics contribute less to the pathogenesis of inflammatory bowel disease and age-related changes (dysbacteriosis, impaired intestinal barrier function, dysregulation of the immune system and regeneration mechanisms) play a more significant role. Ulcerative colitis is more common in older adults. Asymptomatic forms prevail with a relatively stable course. When treating elderly patients the development of geriatric syndromes, multimorbidity, polypharmacy should be taken into account. Particular attention should be paid to the safety of therapy, while maintaining maximum adherence to treatment. Careless prescribing of glucocorticosteroids should be avoided, and if indicated, more often resort to steroid-sparing regimens, especially with the use of 5-aminosalicylic acid preparations, should be used. A prolonged form of mesalazine in the form of microgranules with a semipermeable membrane of ethyl cellulose has a pronounced clinical advantage with a minimal frequency of side effects among this group. When inducing remission in elderly patients with mild to moderate active ulcerative colitis topical glucocorticosteroids may be considered. The advantages of continuing therapy with 5-aminosalicylic acid preparations against the background of the use of genetically engineered biological preparations, thiopurines require further reflection. The risk of surgery in older patients with inflammatory bowel disease is comparable to that of inflammatory bowel disease onset at a young age and does not result in increased surgical morbidity or mortality compared with a younger cohort in the delayed postoperative period.https://journal.lvrach.ru/jour/article/view/1044features of inflammatory bowel diseases in elderly patientsulcerative colitiscrohn's diseasetreatment of inflammatory bowelgeriatrics
spellingShingle L. V. Tarasova
N. Y. Kucherova
T. E. Stepashina
Features of symptoms, diagnosis and treatment of inflammatory bowel diseases in elderly patients
Лечащий Врач
features of inflammatory bowel diseases in elderly patients
ulcerative colitis
crohn's disease
treatment of inflammatory bowel
geriatrics
title Features of symptoms, diagnosis and treatment of inflammatory bowel diseases in elderly patients
title_full Features of symptoms, diagnosis and treatment of inflammatory bowel diseases in elderly patients
title_fullStr Features of symptoms, diagnosis and treatment of inflammatory bowel diseases in elderly patients
title_full_unstemmed Features of symptoms, diagnosis and treatment of inflammatory bowel diseases in elderly patients
title_short Features of symptoms, diagnosis and treatment of inflammatory bowel diseases in elderly patients
title_sort features of symptoms diagnosis and treatment of inflammatory bowel diseases in elderly patients
topic features of inflammatory bowel diseases in elderly patients
ulcerative colitis
crohn's disease
treatment of inflammatory bowel
geriatrics
url https://journal.lvrach.ru/jour/article/view/1044
work_keys_str_mv AT lvtarasova featuresofsymptomsdiagnosisandtreatmentofinflammatoryboweldiseasesinelderlypatients
AT nykucherova featuresofsymptomsdiagnosisandtreatmentofinflammatoryboweldiseasesinelderlypatients
AT testepashina featuresofsymptomsdiagnosisandtreatmentofinflammatoryboweldiseasesinelderlypatients